GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Inventories, Raw Materials & Components

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Inventories, Raw Materials & Components : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Inventories, Raw Materials & Components?

Regencell Bioscience Holdings's inventories, raw materials & components for the quarter that ended in Jun. 2023 was $0.00 Mil.


Regencell Bioscience Holdings Inventories, Raw Materials & Components Historical Data

The historical data trend for Regencell Bioscience Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Inventories, Raw Materials & Components Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Raw Materials & Components
- - - - -

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only - - - - -

Regencell Bioscience Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus